Data gathered: September 16
Alternative Data for DURECT
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 13,000 | Sign up | Sign up | Sign up |
| Google Trends | 59 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 9 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,327 | Sign up | Sign up | Sign up |
| Twitter Followers | 362 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 87 | Sign up | Sign up | Sign up |
About DURECT
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program.
| Price | $1.91 |
| Target Price | Sign up |
| Volume | 2,760,000 |
| Market Cap | $59M |
| Year Range | $0.5 - $1.96 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Biotechnology |
In the news
 |
Bausch Health Companies Inc. (BHC) Acquires DURECT in $413 Million Deal to Tackle Alcoholic HepatitisSeptember 16 - Yahoo Entertainment |
 |
DURECT Sees Unusually Large Options Volume (NASDAQ:DRRX)September 11 - ETF Daily News |
 |
Bausch Health completes acquisition of DURECT CorporationSeptember 11 - Thefly.com |
 |
Bausch Health Companies Inc. (BHC) Expands Hepatology Portfolio with DURECT AcquisitionAugust 29 - Yahoo Entertainment |
Biotech, Pharmaceuticals & Genetics Industry Almanac 2026: Market Research, Statistics, Trends and Leading CompaniesSeptember 11 - GlobeNewswire |
|
|
Bausch Health announces extension of Durect tender offerAugust 26 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 450,000 | 7,000 | 440,000 | -2.3M | -2.3M | -0.070 |
| Q1 '25 | 320,000 | 69,000 | 250,000 | -4.2M | -4.1M | -0.130 |
| Q4 '24 | 450,000 | 22,000 | 430,000 | 7.3M | -4.6M | -0.060 |
| Q3 '24 | 1.9M | 510,000 | 1.4M | -4.3M | -3.9M | -0.140 |
| Q2 '24 | 2.2M | 360,000 | 1.8M | -3.7M | -3.3M | -0.120 |
Insider Transactions View All
| ASEN R SCOTT filed to buy 2,672,529 shares at $1.9. August 26 '25 |
| ASEN R SCOTT filed to buy 2,666,612 shares at $1.9. August 22 '25 |
| ASEN R SCOTT filed to buy 970,000 shares at $1.9. August 22 '25 |
| Robertson Judith J. filed to buy 356,132 shares at $0.9. August 22 '22 |
| Robertson Judith J. filed to buy 346,720 shares at $0.8. August 22 '22 |
Similar companies
Read more about DURECT (DRRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews & linkedin employees.
What is the Market Cap of DURECT?
The Market Cap of DURECT is $59M.
What is the current stock price of DURECT?
Currently, the price of one share of DURECT stock is $1.91.
How can I analyze the DRRX stock price chart for investment decisions?
The DRRX stock price chart above provides a comprehensive visual representation of DURECT's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DURECT shares. Our platform offers an up-to-date DRRX stock price chart, along with technical data analysis and alternative data insights.
Does DRRX offer dividends to its shareholders?
As of our latest update, DURECT (DRRX) does not offer dividends to its shareholders. Investors interested in DURECT should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of DURECT?
Some of the similar stocks of DURECT are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.